Powering next generation targeted immunotherapies, come and meet with our CTO, Shay Tayeb, and learn more about NADAV – our novel oncolytic virus platform technology.
Month: June 2018
ViruCure to attend the Armed Oncolytic Immunotherapies Summit Europe 2018, 26-28 June, Frankfurt, Germany
Meet with our CTO, Shay Tayeb, at the leading end-to-end meeting focused on the next generation of oncolytic virus therapies and discover more about ViruCure’s oncolytic virus technology, NADAV.